期刊文献+

抑癌基因PTEN与子宫内膜腺癌相关性研究 被引量:2

原文传递
导出
摘要 目的:研究抑癌基因PTEN与子宫内膜腺癌恶性生物学行为的相关性。方法:采用免疫组化SP法检测36例子宫内膜腺癌组织中PTEN的表达情况,分析PTEN与各临床病理因素之间的关系。结果:PTEN在子宫内膜腺癌病理分级G1、G2、G3中的阳性表达率分别为80.0%、46.7%、18.2%,三者差异具有统计学意义(H=8.332,P〈0.05),PTEN在肌层浸润深度≤1/2者的阳性率75%〉1/2者的阳性率25%,无淋巴结转移的阳性率为52.6%,而有淋巴结转移的患者无PTEN表达,FIGO分期中Ⅰ期子宫内膜腺癌组织PTEN的阳性表达率57.7%,高于Ⅱ~Ⅳ期的阳性表达率20.0%,差异具有统计学意义,差异无统计学意义(P〈0.05),但PTEN的表达与不同年龄组之间无相关性,差异无统计学意义(P〉0.05)。结论:PTEN与子宫内膜腺癌的发生发展密切相关,可能在子宫内膜腺癌细胞的侵袭转移过程中发挥作用。
出处 《中国妇幼保健》 CAS 北大核心 2014年第31期5157-5159,共3页 Maternal and Child Health Care of China
  • 相关文献

参考文献9

  • 1CerezoL, C6rdenes H, Michael H. Molecular alterations in the pathogenesis of endometrial adenocarcinoma. Therapeutic impli- cations [J] . Clin Transl Oncol, 2006, 8 (4): 231-241.
  • 2Lacey JV Jr, Mutter GL, Ronnett BM, et al. PTEN expression in endometrial biopsies as a marker of progression to endometri- al carcinoma [J] . Cancer Res, 2008, 68 (14): 6014- 6020.
  • 3苗凤台,郭历琛,杨广英,李军.MDM2 PTEN P53在宫颈鳞癌中的表达[J].医药论坛杂志,2008,29(18):43-44. 被引量:1
  • 4Konopka B, Janiec -Jankowska A, Czapczak D, et al. Mo- lecular genetic defects in endometrial carcinomas: microsatelite instability, PTEN and beta - catenin ( CTNNB1 ) genes muta- tions [J] . J Cancer Res Clin Oncol, 2007, 133 (6) : 361 -371.
  • 5Athanassiadou P, Athanassiades P, Grapsa D, et al. The prog- nostic value of PTEN, p53, and beta - catenin in endometrial carcinoma : a prospective immunocytochemical study [J]. Int J Gynecol Cancer ,2007,17 ( 3 ) :697 - 704.
  • 6楼海亚,林开清,叶大风,谢幸,俞晓.PTEN表达能否作为评估子宫内膜样腺癌术前高危因素指标的探讨[J].癌症,2005,24(6):748-750. 被引量:5
  • 7Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumour supperssor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers [J] . Nat Genet, 1997, 15 (4): 356-362.
  • 8Konopka B, Paszko Z, Janiec - Jankowska A, et al. Assess- ment of the quality and frequency of mutations occurrence in PTEN gene in endometrial carcinomas and hyperplasias [J] . Cancer Lett, 2006, 178 (1) : 43 -51.
  • 9段亚军.MDM2和PTEN在宫颈鳞癌中的表达意义[J].山东医药,2007,47(34):89-90. 被引量:2

二级参考文献13

  • 1王东红,孙丽君,邓卫安,明祖谦.mdm2蛋白在子宫颈上皮内瘤样病变和子宫颈癌中的表达[J].新医学,2005,36(2):73-74. 被引量:10
  • 2秦天生,杨凤云,杨毓琴.Fhit、p53表达与子宫内膜癌发生和发展的相关性[J].临床与实验病理学杂志,2005,21(1):73-76. 被引量:6
  • 3Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer [J]. Science, 1997,275(5308):1943-1947.
  • 4Mutter GL, Lin MC, Fitzgerald JT, et al. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers [J]. J Natl Cancer Inst, 2000,92 (11): 924-930.
  • 5Kimura F, Watanabe J, Hata H, et al. PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus [J]. J Cancer Res Clin Oncol, 2004, 130(3): 161-168.
  • 6Konopka B, Paszko Z, Janiec-Jankowska A, et al. Assessment of the quality and frequency of mutations occurrence in PTEN gene in endometrial carcinomas and hyperplasias [J]. Cancer Lett, 2002,178 (1) :43-51.
  • 7Kurose K, Zhou XP, Araki T, et al. Biallelic inactivating mutations and an occult germ line utation of PTEN in primary cervical carcinomas[ J]. Genes Chromosomes Cancer, 2000,29 (2) : 166-172.
  • 8Weissman AM. Themes and variations on ubiquitylation [J]. Nat Rev Mol Cell Biol, 2001,2(3) :169-178
  • 9Kurose K, Zhou XP, A raki T, et al. Biallelic inactivating mutations and an occult germ line utation of PTEN in primary cervical carcinomas [ J ]. Genes Chromosomes Cancer, 2000,29(2) :166-172
  • 10凌箫鸣,郑英,张涛.宫颈上皮内瘤样病变及鳞癌中p53与MDM2蛋白表达差异性研究[J].肿瘤防治研究,2000,27(6):483-485. 被引量:11

共引文献5

同被引文献20

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部